in male rats. Comparison of the metabolic profile of NNEI to its indazole analogue MN-18 disclosed marked discrepancies in pharmacokinetic parameters and metabolic pathways. It should be talked about that compound 183 confirmed apparent ocular hypotensive action, outstanding in magnitude for The full study course in the experiment. The main t